BioSpace News Archive

Paradigm Healthcare, an independently-owned healthcare management company, operates under the mantra “Exemplary Care by Exemplary People.”

Akebia Therapeutics, Inc. (Nasdaq:AKBA) (“Akebia” or the “Company”) today announced that leading independent proxy advisory firm, Glass Lewis & Co. (“Glass Lewis”), joins Institutional Shareholder Services (“ISS”) in recommending that Akebia shareholders vote “FOR” the shareholder proposals relating to the Company’s proposed merger with Keryx Biopharmaceuticals (Nasdaq:KERX).

Oncologists are growing more confident in their ability to meet the requirements of the Medicare Access & CHIP Reauthorization Act (MACRA), according to new research from Cardinal Health Specialty Solutions.

Shaklee Corporation (www.shaklee.com), a leading natural nutrition company, is proud to announce the addition of world-renowned sports physiologist Dr. Genadijus Sokolovas and Sarah Scherer-Oursland, a registered dietician and nutritionist for the Shaklee Pure Performance Team.

One of Three Specialty Pharmacy Partners Across the Nation

Air Methods, the leading air medical service, announced today that David Richardson, senior vice president customer experience, and Martin Delaney, regional vice president, Midwest region, were both honored with Patriot Awards, a U.S. Department of Defense honor that recognizes employers who demonstrate outstanding support and flexibility for employees who proudly serve their country in the National Guard and Reserve.

New data demonstrate increasing use of MRD in multiple myeloma and acute lymphoblastic leukemia clinical trials to assess response to therapy

Spectrum Pharmaceuticals today announced presentations of clinical and scientific data related to Peripheral T-cell Lymphoma (PTCL) and EVOMELA® (melphalan) at the 60th Annual Meeting of the American Society of Hematology (ASH) being held in San Diego, California, from December 1-4, 2018.

LabCorp® today updated its full-year 2018 guidance based on current expectations. In the following guidance, all comparisons to financial results in 2017 have been restated as if the Company had adopted the FASB-issued converged standard on revenue recognition (ASC 606) on January 1, 2017.

Further Regulatory Submissions Ongoing with Authorities Worldwide